These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 31373030)
1. Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approach. Evers RAF; van Vliet D; van Spronsen FJ J Inherit Metab Dis; 2020 Mar; 43(2):189-199. PubMed ID: 31373030 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study. Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246 [TBL] [Abstract][Full Text] [Related]
3. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria. Trefz FK; Blau N Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666 [TBL] [Abstract][Full Text] [Related]
4. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrations. van Vliet D; Anjema K; Jahja R; de Groot MJ; Liemburg GB; Heiner-Fokkema MR; van der Zee EA; Derks TG; Kema IP; van Spronsen FJ Mol Genet Metab; 2015 Jan; 114(1):29-33. PubMed ID: 25466353 [TBL] [Abstract][Full Text] [Related]
5. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria. Fiege B; Blau N J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248 [TBL] [Abstract][Full Text] [Related]
6. Response of patients with phenylketonuria in the US to tetrahydrobiopterin. Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of tetrahydrobiopterin (BH4) responsive mild phenylketonuria in Japan over the past 10 years. Shintaku H; Ohwada M; Aoki K; Kitagawa T; Yamano T Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):77-2. PubMed ID: 19904458 [TBL] [Abstract][Full Text] [Related]
8. Early Screening for Tetrahydrobiopterin Responsiveness in Phenylketonuria. Porta F; Spada M; Ponzone A Pediatrics; 2017 Aug; 140(2):. PubMed ID: 28679641 [TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Hennermann JB; Bührer C; Blau N; Vetter B; Mönch E Mol Genet Metab; 2005 Dec; 86 Suppl 1():S86-90. PubMed ID: 16051511 [TBL] [Abstract][Full Text] [Related]
11. Effects and clinical significance of tetrahydrobiopterin supplementation in phenylalanine hydroxylase-deficient hyperphenylalaninaemia. Gramer G; Burgard P; Garbade SF; Lindner M J Inherit Metab Dis; 2007 Aug; 30(4):556-62. PubMed ID: 17680344 [TBL] [Abstract][Full Text] [Related]
12. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency. Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839 [TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Pérez-Dueñas B; Vilaseca MA; Mas A; Lambruschini N; Artuch R; Gómez L; Pineda J; Gutiérrez A; Mila M; Campistol J Clin Biochem; 2004 Dec; 37(12):1083-90. PubMed ID: 15589814 [TBL] [Abstract][Full Text] [Related]
14. The tetrahydrobiopterin loading test in 36 patients with hyperphenylalaninaemia: evaluation of response and subsequent treatment. Bóveda MD; Couce ML; Castiñeiras DE; Cocho JA; Pérez B; Ugarte M; Fraga JM J Inherit Metab Dis; 2007 Oct; 30(5):812. PubMed ID: 17603758 [TBL] [Abstract][Full Text] [Related]
15. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Fiege B; Bonafé L; Ballhausen D; Baumgartner M; Thöny B; Meili D; Fiori L; Giovannini M; Blau N Mol Genet Metab; 2005 Dec; 86 Suppl 1():S91-5. PubMed ID: 16290003 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study. Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience. Scala I; Concolino D; Della Casa R; Nastasi A; Ungaro C; Paladino S; Capaldo B; Ruoppolo M; Daniele A; Bonapace G; Strisciuglio P; Parenti G; Andria G Orphanet J Rare Dis; 2015 Feb; 10():14. PubMed ID: 25757997 [TBL] [Abstract][Full Text] [Related]
18. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria. Erlandsen H; Stevens RC J Inherit Metab Dis; 2001 Apr; 24(2):213-30. PubMed ID: 11405341 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters. Yano S; Moseley K; Fu X; Azen C PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937 [TBL] [Abstract][Full Text] [Related]
20. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria. Michals-Matalon K Expert Opin Investig Drugs; 2008 Feb; 17(2):245-51. PubMed ID: 18230057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]